patent infringement
FDA’s Dr. Gottlieb Chastises Big Pharma for Biosimilar Entry Delays
Of the 11 biosimilars approved by the FDA, only three have reached the U.S. market.
JULY 20, 2018
ViiV Files Suit Against Gilead Over HIV Drug Patents
ViiV claims bictegravir infringes on its patent covering dolutegravir and many other compounds that include ...
FEBRUARY 8, 2018
Load more